These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19024070)

  • 1. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Andeweg J; van Grinsven M
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2366; author reply 2366. PubMed ID: 19024070
    [No Abstract]   [Full Text] [Related]  

  • 2. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH; Buitelaar JK
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and harms of pediatric antidepressant medications.
    Edwards JL; Kirk KK; Midha CK
    JAMA; 2007 Aug; 298(6):626-7; author reply 627. PubMed ID: 17684183
    [No Abstract]   [Full Text] [Related]  

  • 5. Adolescents with depression.
    Carroll BJ
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572711
    [No Abstract]   [Full Text] [Related]  

  • 6. Adolescents with depression.
    Bridge JA; Brent DA
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572710
    [No Abstract]   [Full Text] [Related]  

  • 7. Adolescents with depression.
    Antonuccio D; Burns D
    JAMA; 2004 Dec; 292(21):2577; author reply 2578-9. PubMed ID: 15572709
    [No Abstract]   [Full Text] [Related]  

  • 8. Adolescents with depression.
    Rifkin A; Rifkin W
    JAMA; 2004 Dec; 292(21):2577-8; author reply 2578-9. PubMed ID: 15572708
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of adolescents with major depression: contributions of a major trial.
    Glass RM
    JAMA; 2004 Aug; 292(7):861-3. PubMed ID: 15316001
    [No Abstract]   [Full Text] [Related]  

  • 10. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing for depressed adolescents: office decision-making in the face of limited research evidence.
    Gordon M; Melvin GA
    J Paediatr Child Health; 2014 Jul; 50(7):498-503. PubMed ID: 24617419
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching to bupropion in fluoxetine-resistant major depressive disorder.
    Fava M; Papakostas GI; Petersen T; Mahal Y; Quitkin F; Stewart J; McGrath P
    Ann Clin Psychiatry; 2003 Mar; 15(1):17-22. PubMed ID: 12839429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adolescent depression: what we have come to know.
    Vitiello B
    Depress Anxiety; 2009; 26(5):393-5. PubMed ID: 19404989
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2
    Sales MC; Kasahara TM; Sacramento PM; Rossi ÁD; Cafasso MOSD; Oyamada HAA; Hygino J; Alvim F; Andrade RM; Cristina Vasconcelos C; Bento CAM
    Immunology; 2021 Mar; 162(3):290-305. PubMed ID: 33112414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reaction on 'Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines'].
    Moleman P
    Tijdschr Psychiatr; 2010; 52(11):801-2; author reply 802-4. PubMed ID: 21064023
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine: therapeutic and undesirable effects.
    Cookson J; Duffett R
    Hosp Med; 1998 Aug; 59(8):622-6. PubMed ID: 9829055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.